Category: Nevin Manimala

J Neurol Sci. 2022 Feb 24;436:120205. doi: 10.1016/j.jns.2022.120205. Online ahead of print.

ABSTRACT

INTRODUCTION: Despite differences in the pathogenesis and treatment of multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD), it remains difficult to distinguish them. In this study, we aimed to discriminate between MS and NMOSD using diffusion tensor imaging (DTI), free water (FW) imaging, and neurite orientation dispersion and density imaging (NODDI).

METHODS: Thirty patients with relapsing-remitting (RR) MS, 18 NMOSD patients with positive anti-aquaporin-4 immunoglobulin G seroreactivity, and 20 age- and sex- matched currently healthy subjects underwent MRI. The differences in the DTI (fractional anisotropy [FA], axial diffusivity [AD], mean diffusivity [MD], and radial diffusivity [RD]), FW and FW-corrected DTI, and NODDI indices between the three groups were evaluated using tract-based spatial statistics (TBSS) and region-of-interest (ROI) analyses.

RESULTS: The ROI analysis of lesions indicated that the RRMS group had significantly higher AD, MD, RD, ISO and FW-corrected AD, and MD; and lower intracellular volume fraction (ICVF) than the NMOSD group. TBSS analysis showed increased water content in RRMS patients compared to NMOSD patients. Compared with healthy controls (HCs) using TBSS and ROI analysis, the changes in FW imaging indices were more limited than those of in DTI in RRMS patients.

CONCLUSION: FW imaging and NODDI were useful for identifying the etiology of neurodegeneration- and neuroinflammation-related microstructural changes in RRMS and NMOSD patients.

PMID:35259556 | DOI:10.1016/j.jns.2022.120205

Acad Pediatr. 2022 Mar 5:S1876-2859(22)00090-0. doi: 10.1016/j.acap.2022.02.020. Online ahead of print.

NO ABSTRACT

PMID:35259547 | DOI:10.1016/j.acap.2022.02.020

Transl Res. 2022 Mar 5:S1931-5244(22)00043-3. doi: 10.1016/j.trsl.2022.02.009. Online ahead of print.

ABSTRACT

Whether hepatitis C virus (HCV) infection is associated with breast cancer risk remains elusive, and we aimed to elucidate it. A nationwide population-based cohort study of the Taiwan National Health Insurance Research Database (TNHIRD) was conducted. Additionally, breast cancer risk factors and HCV core expression were surveyed in breast cancer patients of a tertiary care center. Three TNHIRD cohorts (1:4:4, propensity score-matched, 2003-2012), including HCV-treated (3,646 HCV-infected females with interferon-based therapy ≥ 6 months), HCV-untreated (n=14,584) and HCV-uninfected (n=14,584) cohorts, were enrolled. The HCV-untreated cohort had the highest 9-year breast cancer cumulative incidence [2.017%; 95% confidence interval (CI): 1.382-2.846%], while the HCV-treated (1.073%; 0.414-2.356%) and HCV-uninfected (1.453%; 0.785-2.486%) cohorts showed no difference. Untreated HCV infection [hazard ratio (HR): 1.701; 95% CI: 1.205-2.400], urban residency (1.658, 1.183-2.323) and baseline cardiovascular events (1.920; 1.005-3.668) were associated with incident breast cancers. The interaction analysis showed that particularly among patients <49 years, HCV infection was associated with breast cancer development (2.193; 1.097-4.384). Of 12,170 hospitalized breast cancer patients, 4.90% were HCV Ab-positive. HCV Ab-positive patients were older (60.92+/-10.82 vs. 53.91+/-11.38 years, p<0.0001) and had a higher body mass index (25.39+/-5.1 vs. 24.5+/-4.3 kg/m², p=0.007), rates of diabetes (30.60 vs. 19.98%, p<0.0001), hypertension (46.9 vs. 30.39%, p<0.0001), dyslipidemia (25.52 vs. 20.28%, p=0.031) and hyperuricemia (11.38 vs. 5.52%, p<0.0001) than their counterparts. No HCV core-positive cells were demonstrated in breast cancer tissues. Conclusions: Untreated HCV infection, urbanization, and cardiovascular events were potential risk factors for breast cancer. The HCV-associated risk was most prominent among patients < 49 years, might not be associated with in situ HCV core-related oncogenesis but with metabolic alterations and was reversed by anti-HCV therapy.

PMID:35259528 | DOI:10.1016/j.trsl.2022.02.009

J Vasc Surg Venous Lymphat Disord. 2022 Mar 5:S2213-333X(22)00096-8. doi: 10.1016/j.jvsv.2022.01.012. Online ahead of print.

ABSTRACT

OBJECTIVE: To evaluate the utility of a published clinical decision support tool to predict the likelihood of a retrievable inferior vena cava (IVC) filter being maintained as a permanent device.

METHODS: This multicenter retrospective cohort study included 1,498 consecutive patients (852 men,646 women; median age 60 years (range 18-98 years) who underwent retrievable IVC filter insertion between 1/2012-12/2019. Indication for IVC filtration, baseline neurologic disease, history of venous thromboembolism(VTE), and underlying malignancy were recorded. Accuracy, sensitivity, and specificity of a published clinical support tool were calculated to determine the utility of the tool.

RESULTS: The majority (1,271/1,498;85%) of filters were placed for VTE with a contraindication to anticoagulation. A history of VTE was present in 811/1,498(54%) patients; underlying malignancy in 531/1,498(35%) patients, and neurological disease in 258/1,498(17%) patients. Of 1,498 filters, 456(30%) were retrieved, 276(18%) filters were maintained as permanent devices on follow-up, and 766 (51%) filters were not retrieved. Accuracy of the clinical prediction model was 61%, sensitivity was 60%, and specificity was 62%.

CONCLUSION: A previously published clinical decision support tool to predict permanence of IVC filters had modest utility in the examined population; this should be taken into account when utilizing this clinical decision support tool outside of the original study population. Future studies are required to refine the predictive capability of IVC filter decision support tools for broader use across different patient populations.

PMID:35259532 | DOI:10.1016/j.jvsv.2022.01.012

World Neurosurg. 2022 Mar 5:S1878-8750(22)00286-8. doi: 10.1016/j.wneu.2022.03.005. Online ahead of print.

ABSTRACT

OBJECTIVES: This study aimed to clarify functional outcomes of facet joint distraction (FJD) and identify specific risk factors for excessive FJD during single-level anterior cervical discectomy and fusion (ACDF) for cervical spondylotic myelopathy (CSM).

METHODS: This study retrospectively analyzed 100 patients who underwent single-level ACDF for CSM from January 2016 to May 2020. Anteroposterior and lateral radiographs were obtained before surgery and 12 months after surgery. Radiographic parameters, including anterior intervertebral height (AIH), posterior intervertebral height, facet joint gap, cage posterior depth (CPD), upper vertebral length, cervical segmental cobb angle (CSCA), C2-C7 cobb angle and C2-C7 sagittal vertical axis were analyzed. Functional outcomes were evaluated using the modified Japanese Orthopedic Association Score (mJOA), Visual Analog Scale (VAS) and Neck Disability Index (NDI).

RESULTS: Comparison between the appropriate facet joint distraction and excessive facet joint distraction groups showed statistically significant differences in the NDI, VAS, CPD and ΔAIH (P<0.05). Multivariate logistic regression analysis showed independent factors associated with excessive FJD were: a ΔAIH>2.28mm (OR=6.792, 95%CI=1.885-24.470, P=0.003), CPD>12.45mm (OR=5.876, 95%CI=1.828-18.895, P=0.003) and post-CSCA<0° (OR=6.251, 95%CI=1.275-30.633, P=0.024). Furthermore, ROC curve analysis for the multi-level logistic regression model produced an area under the curve of 0.783 (P<0.001).

CONCLUSION: Patients with an FJD>0.905 mm had worse NDI and VAS pain scores, but not a poorer mJOA recovery rate. Our findings suggested that a ΔAIH>2.28 mm, CPD>12.45 mm and post-CSCA<0° were independent risk factors for excessive FJD after single-level ACDF for CSM.

PMID:35259505 | DOI:10.1016/j.wneu.2022.03.005

World Neurosurg. 2022 Mar 5:S1878-8750(22)00273-X. doi: 10.1016/j.wneu.2022.02.126. Online ahead of print.

ABSTRACT

OBJECTIVE: To evaluate the accuracy of using patient-specific drill guides to place bilateral laminar screws in C1 and C2.

METHODS: Nine cervical specimens (8 male; mean age: 66.6 (56-73)) with the occiput attached (C0-C3) were used in this study. Pre-operative CT scans were used to create digital anatomic models for templating and guide creation. A total of 36 screws were placed with the aid of 3D printed patient-specific guides (2 screws at C1 and C2). Post-operative CT scans were performed following screw insertion. The planned and actual trajectories were compared using pre- and post-operative imaging based on the angular and entry point deviation. After screw placement and post-operative imaging, each specimen was dissected and performed a visual inspection for breaches.

RESULTS: No breaches or violations were observed on post-procedure CT and visual inspection. The average variation of the entry point in the X, Y, and Z-axis was 0.3±0.28, 0.41±0.38, and 0.29±0.24, respectively. No statistically significant difference (p>0.05) was observed between the planned and obtained entry points. There was no significant difference (p>0.05) in the deviation analysis between the planned and obtained angles in the axial and coronal planes.

CONCLUSION: The study demonstrates that patient-specific drill guides allow for accurate C1 and C2 bilateral laminar screw placement, with a low risk of cortical breach.

PMID:35259502 | DOI:10.1016/j.wneu.2022.02.126

Clin Cancer Res. 2022 Mar 8:clincanres.4462.2021. doi: 10.1158/1078-0432.CCR-21-4462. Online ahead of print.

ABSTRACT

On August 25, 2021, the FDA approved ivosidenib for the treatment of adult patients with unresectable locally advanced or metastatic hepatocellular isocitrate-dehydrogenase-1 (IDH1) mutated cholangiocarcinoma (CCA) as detected by an FDA-approved test with disease progression after 1-2 prior lines of systemic therapy for advanced disease. The approval was based on data from Study AG120-C-005 (ClarIDHy), a double-blind placebo-controlled trial which randomly allocated (2:1) patients to receive either ivosidenib or placebo. Independently-assessed progression free survival (PFS) was the primary endpoint. With a median follow up of 6.9 months, the hazard ratio for PFS was 0.37 (95% confidence interval 0.25, 0.54, p&lt; 0.0001). Overall survival (OS) was the key secondary endpoint. At the final analysis of OS, with 70.5% patients in the placebo arm receiving ivosidenib post disease progression, a non-statistically significant improvement in the ivosidenib arm with a HR = 0.79 (95% CI: 0.56, 1.12) and median OS of 10.3 months (95% CI 7.8, 12.4) and 7.5 months (95% CI 4.8, 11.1) in the ivosidenib and placebo arms respectively were reported. Adverse reactions occurring in &gt;20% of patients receiving ivosidenib were fatigue/asthenia, nausea, diarrhea, abdominal pain, ascites, vomiting, cough, and decreased appetite. Adverse reactions occurring in &gt;20% of patients receiving placebo were fatigue/asthenia, nausea, abdominal pain, and vomiting. This is the first approval for the subset of patients with CCA harboring an IDH1 mutation.

PMID:35259259 | DOI:10.1158/1078-0432.CCR-21-4462

PLoS One. 2022 Mar 8;17(3):e0265034. doi: 10.1371/journal.pone.0265034. eCollection 2022.

ABSTRACT

We analyzed data from a cohort of Black and Latino men who have sex with men (MSM) in order to identify correlates of prevalent and incident incarceration, including potential predictors related to their status as sexual and gender minorities (SGMs). Baseline and follow-up self-administered survey data were examined from Los Angeles County participants’ ages 18-45 years at enrollment who were either HIV negative or living with HIV, but recruited to over represent men who used drugs and men with unsuppressed HIV infection. Multivariable logistic regression models were developed to identify predictors of baseline incarceration history and of incident incarceration over study follow-up among 440 and 338 participants, respectively. Older age, Black race, low socioeconomic status, homelessness, stimulant use, and depression symptoms were associated with baseline incarceration history. The only SGM-related factor associated with baseline incarceration history was having experienced violence based on sexual orientation identity. Just one statistically significant, independent positive predictor of incident incarceration was identified: prior incarceration, whereas having four or more friends that could lend money was a statistically significant protective factor against incident incarceration. Fundamental Cause Theory provides a useful framework to explain identified predictors of incarceration. Addressing poverty, housing instability, inadequate access to health care, and their root causes is critical to reducing incarceration rates in this population, as is expanded access to both diversion and anti-recidivism programs and to evidence-based treatment for stimulant use disorders.

PMID:35259198 | DOI:10.1371/journal.pone.0265034

PLoS One. 2022 Mar 8;17(3):e0264993. doi: 10.1371/journal.pone.0264993. eCollection 2022.

ABSTRACT

CONTEXT: The prevalence of overweight and obesity in Saudi Arabia has been rising. Although the health burden of excess weight is well established, little is known about the economic burden.

AIMS: To assess the economic burden-both direct medical costs and the value of absenteeism and presenteeism-resulting from overweight and obesity in Saudi Arabia.

SETTINGS AND DESIGN: The cost of overweight and obesity in Saudi Arabia was estimated from a societal perspective using an epidemiologic approach.

METHODS AND MATERIALS: Data were obtained from previously published studies and secondary databases.

STATISTICAL ANALYSIS USED: Overweight/obesity-attributable costs were calculated for six major noncommunicable diseases; sensitivity analyses were conducted for key model parameters.

RESULTS: The impact of overweight and obesity for these diseases is found to directly cost a total of $3.8 billion, equal to 4.3 percent of total health expenditures in Saudi Arabia in 2019. Estimated overweight and obesity-attributable absenteeism and presenteeism costs a total of $15.5 billion, equal to 0.9 percent of GDP in 2019.

CONCLUSIONS: Even when limited to six diseases and a subset of total indirect costs, results indicate that overweight and obesity are a significant economic burden in Saudi Arabia. Future studies should identify strategies to reduce the health and economic burden resulting from excess weight in Saudi Arabia.

PMID:35259190 | DOI:10.1371/journal.pone.0264993

PLoS One. 2022 Mar 8;17(3):e0264944. doi: 10.1371/journal.pone.0264944. eCollection 2022.

ABSTRACT

Catatonia is a psychomotor abnormality caused by neurological, medical or severe psychiatric disorders and substances. Its prevalence ranges from less than 10% to just above 60%. Diagnosis may be influenced by the screening tools used. Screening of new admissions to a mental health unit for catatonia was undertaken using three instruments to determine prevalence of catatonia. Participants ranged from age 16 years and over. Recruitment took place from September 2020 to August 2021. The setting was a mental health unit within a general hospital in Nelson Mandela Metro, South Africa. Five assessors were trained by the principal investigator to apply the Bush Francis Screening Instrument (BFCSI), the Bush Francis Catatonia Rating Scale (BFCRS), and the Diagnostic and Statistical Manual 5 (DSM-5), to assess participants. Clinical and demographic data were collected using a specially designed datasheet. Data analysis was performed to identify significant associations between presence or absence of catatonia and clinical and demographic data. Up to 241 participants were screened and 44 (18.3%) had catatonia. All 44 cases were identified through the BFCSI while the DSM-5 identified only 16 (6.6%%) of the 44 cases even though the remaining 28 (63.6%) participants still required treatment for catatonic symptoms. The DSM-5 diagnostic criteria excluded staring, which was the commonest sign of catatonia identified through the BFCSI [n = 33 (75%)]. Close to half (21; 47.7%) of those with catatonia on the BFCSI had schizophrenia. The rest had bipolar disorder (12; 27.3%), substance-induced psychotic disorder (7; 15.9%) and no specified diagnosis in one (1; 2.6%). The BFCSI was very effective at identifying catatonia while the DSM-5 was inadequate, missing close to 64% (28 of 44) of cases. Predictors of catatonia in this sample were a younger age and being male. A prevalence of 18.3%, indicates that assessment for catatonia should be routinely conducted in this and similar settings.

PMID:35259194 | DOI:10.1371/journal.pone.0264944